Clinical Trial Update: Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from Fudan University investigates combining transcatheter arterial chemoembolization with anti-hepatitis B virus therapy for he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: UNKNOWN